申请人:E.R. Squibb & Sons, Inc.
公开号:EP0071544A1
公开(公告)日:1983-02-09
New phosphonamidate substituted imino or amino acid compounds, and pharmaceutically acceptable salts thereof, as described herein, possess angiotensin converting enzyme activity and are thus useful as anti-hypertensive agents.
本文所述的新型膦酰胺取代的亚氨基或氨基酸化合物及其药学上可接受的盐类具有血管紧张素转换酶活性,因此可用作抗高血压药物。